The updated guidance from the US Multi-Society Task Force on Colorectal Cancer marks a significant shift toward more personalized, patient-centered bowel preparation for colonoscopy. The new recommendations emphasize improved patient education, allow for lower-volume and same-day prep regimens in select patients, and offer more flexible dietary restrictions based on individual risk. Critically, the task force now recommends tracking bowel prep adequacy at both provider and unit levels, raising the benchmark from 85% to 90%. Experts say these timely updates could improve patient adherence, satisfaction, and ultimately, colorectal cancer prevention outcomes.
Trending
- U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer (Pfizer)
- Oshi Health’s 2025 Impact Report Demonstrates Exceptional GI Outcomes and Cost Savings at Scale (PR Newswire)
- Medtronic announces CE Mark for the next generation GI Genius™ module and ColonPRO™ software (Medtronic)
- Allurion gets FDA nod for weight loss balloon (Mass Device)
- The 7 Must-Haves For The Doctor Of the 21st Century (The Medical Futurist)
- Will AI Eventually De-Skill Doctors? The Evidence Is Trickling In (Forbes)
- CRC Screening by Colonoscopy and FIT Improves Early Detection over Usual Care (Inside Precision Medicine)
- It’s Called the ‘Fitbit for Farts’—and It’s No Joke (The Wall Street Journal)
